CAS 1401436-95-0

4-[2-(Difluoromethyl)-1H-benzimidazol-1-yl]-N-[1,1-dimethyl-2-[2-(1-methyl-4-piperidinyl)phenyl]ethyl]-6-(4-morpholinyl)-1,3,5-triazin-2-amine

CAS: 1401436-95-0

Fórmula: C₃₁H₃₈F₂N₈O

Pureza: 98%

Forma y color: Solid

Peso molecular: 576.6832

Ref: IN-DA001C2J

Zandelisib

CAS: 1401436-95-0

Zandelisib

Pureza: ≥98%

Peso molecular: 576.68g/mol

Ref: 54-BUP08765

Zandelisib-13c-d3

CAS: 1401436-95-0

Fórmula: C₃₀₁₃CH₃₅D₃F₂N₈O

Peso molecular: 580.71

Ref: 4Z-Z-040002

Zandelisib

CAS: 1401436-95-0

Fórmula: C₃₁H₃₈F₂N₈O

Peso molecular: 576.70

Ref: 4Z-Z-040001

Zandelisib

CAS: 1401436-95-0

Zandelisib is an inhibitor of phosphatidylinositol 3-kinase (PI3K)(p110δ, IC50 of 3.5 nM), and with antineoplastic activity.

Fórmula: C₃₁H₃₈F₂N₈O

Pureza: 99.88%

Forma y color: Solid

Peso molecular: 576.68

Ref: TM-T13386

Zandelisib

CAS: 1401436-95-0

Zandelisib is a cell-permeable peptide ligand that binds to the extracellular domain of human EGFR. It has been shown to inhibit receptor activation and signaling, as well as receptor-mediated endocytosis. Zandelisib also inhibits protein interactions with receptors, including those of the epidermal growth factor family.

Fórmula: C₃₁H₃₈F₂N₈O

Pureza: Min. 95%

Peso molecular: 576.7 g/mol

Ref: 3D-BGC43695